Behavioral Management of Phosphorus in Hemodialysis Patients

Status Completed

Clinical Trial Summary

The purpose of this randomized clinical trial is to evaluate alternative technology-supported behavioral approaches to engaging 42 maintenance hemodialysis (HD) patients with persistent hyperphosphatemia in phosphorus binder adherence and dietary phosphorus restriction. Participants will be randomized to 1 of 3 intervention groups: (1) Education (Edu); (2) Edu + Self-Monitoring (SM); or (3) Edu + SM + Social Cognitive Theory (SCT)-based training program.

Clinical Trial Description

Investigators will evaluate the intervention in terms of feasibility and acceptability, behavior change at 12 and 24 weeks (reported phosphorus binder adherence, reported nutrient intakes, normalized protein catabolic rate), and clinical outcomes (serum phosphorus concentrations, symptoms). In addition, the impact of the different behavioral approaches on self-efficacy at 12 and 24 weeks, and the mediating effects of self-efficacy in facilitating behavioral changes and clinical outcomes will be examined. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02940743
Study type	Interventional
Source	New York University School of Medicine
Contact
Status	Completed
Phase	N/A
Start date	April 23, 2018
Completion date	May 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT02237534` - Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia	Phase 4
Unknown status	`NCT01245517` - The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient	N/A
Completed	`NCT01252771` - Phosphate Kinetic Modeling 2	Phase 4
Completed	`NCT01187628` - Long-term Study in Chronic Kidney Disease (Extension From Study 14817)	Phase 3
Completed	`NCT00506441` - A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia	Phase 3
Recruiting	`NCT04440696` - To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder	Phase 1/Phase 2
Completed	`NCT01976572` - Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects	Phase 1
Completed	`NCT01742585` - A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis	Phase 3
Completed	`NCT01191255` - A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis	Phase 3
Completed	`NCT01003223` - Phosphate Kinetic Modeling	N/A
Completed	`NCT00505037` - A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis	Phase 2
Completed	`NCT00508885` - The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients	Phase 1/Phase 2
Completed	`NCT04551300` - A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients	Phase 2
Completed	`NCT01955876` - Fosrenol Post-marketing Surveillance in Japan	N/A
Completed	`NCT04579315` - Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease	N/A
Completed	`NCT03861247` - Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients	Phase 3
Terminated	`NCT01725113` - Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol	Phase 4
Recruiting	`NCT01238588` - The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan	N/A
Completed	`NCT00542815` - A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia	Phase 3
Completed	`NCT04549597` - Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia	Phase 4